Topics in Drug Testing from Quest Diagnostics

Topics in Drug Testing from Quest Diagnostics

By questdrugtestingHealth & Fitness
Download on the App Store

Topics in Drug Testing from Quest Diagnostics episodes

  • Pharmacogenomics in mental health and addiction
    Today’s podcast discussion will focus on clinical care for patients with mental health disorders. Will discuss and share information regarding:
    Mental health disorder and substance abuse prevalence
    The clinical utility of pharmacogenomics in mental health and addiction
    Mental health disorders and medication nonadherence
    The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Director, Medical Science Liaison—Neurology and Pharmacogenomics, Raymond Lorenz.
    ----more----
    You may download a PDF version of this presentation here >>
    To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics’ comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    31 min
  • Implementing a Drug Monitoring Protocol in your practice
    Today’s podcast discussion will focus on appropriate steps to take to implement an effective Drug Monitoring Protocol in your practice. Key information shared will include:
    Some of the key challenges facing clinicians today
    Important steps to take for implementing a responsible drug monitoring protocol
    How Quest can help
    The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Senior Product Manager Jason Suomala, for the Quest Diagnostics Drug Monitoring and Toxicology division.
    ----more----
    You may download a PDF version of this presentation here >>
    To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts.  At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    20 min
  • Alternative Specimen Collection Options
    Today’s podcast discussion will focus on the importance of drug monitoring and the benefits of “alternative” sample collection options during the COVID-19 pandemic. Key information shared will include:
    How clinical drug monitoring is a critical tool to help assess prescription compliance with controlled substances and help identify drug misuse
    Situations, including the COVID-19 pandemic, when in-office collection isn't always possible
    Quest Diagnostics’ offerings for alternative specimen collection options, including:- Self /At-Home collection- Patient Service Center collection
    How alternative collection options can help ensure your patients get the testing they need
    The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin, and Jason Suomala, Senior Product Manager for the Quest Diagnostics Drug Monitoring and Toxicology division.
    ----more----
    You may download a PDF version of this presentation here >>
    To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    18 min
  • The epidemic within the pandemic
    Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions discussed will include:
    Clinical drug testing decreased significantly during the pandemic period
    Nonprescribed positivity for fentanyl, heroin, and other drugs of concern increased significantly
    Many dangerous drug combinations, including combinations with fentanyl,  increased significantly
    The impact of the COVID-19 pandemic on the treatment of patients at risk for substance use disorder
    The role of clinical drug monitoring
    This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™.
    ----more----
    You may download a PDF version of this presentation here >>
    25 min
  • Drug testing for stimulants
    Today’s podcast will cover drug testing for stimulants and will highlight some of the challenges in results interpretation for this class of drugs. Important information shared during the discussion will include:
    What is classified as a stimulant
    Analysis of Amphetamine, Methamphetamine, and MDMA
    Interpretation challenges
    Synthetic stimulants
    The role of clinical drug monitoring
    Quest Diagnostics amphetamine drug testing offering
     
    The episode features Dr Les Edinboro, PhD, executive science director, and Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology.
    ----more----
     
    You may download a PDF version of this presentation here >>
     
    To listen to other podcasts in our “Topics in Drug Testing” series, or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.
    30 min
  • Drug Monitoring in Behavioral Health and during times of crisis
    Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:
    Mental Health disorders, diagnosis and prevalence
    The challenge of medication adherence in mental health treatment
    The impact of crises on the treatment of patients with mental health conditions
    The role of clinical drug monitoring
     
    The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.
    ----more----
     
    You may download a PDF version of this presentation here >>
     
    To listen to other podcasts in our Topics in Drug Testing series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    26 min
  • Drug Misuse in America
    Today’s podcast will cover key findings from the annual Quest Diagnostics Health Trends report, Drug Misuse in America. Some of the key topics shared will include:
    Summary of analysis of more than 4.4 million de-identified drug monitoring tests performed by Quest Diagnostics from 2011 through 2018
    Findings of a Harris Poll survey of 500 primary care physicians, as part of Health Trends report analysis
    Highlights of the evolving drug misuse crisis in America, including Drug mixing and the overdose death connection
    Key challenges facing physicians today, with regards to identifying drug misuse, and treating patients with chronic pain
    The role and importance of drug monitoring and incorporating it into medical practice
    This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™. 
    ----more----
    You may download a PDF version of this presentation here>>
    To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    21 min
  • Kratom: Identifying ”a drug of concern”
    Today’s podcast will cover testing for kratom, a drug of concern. Some of the key information shared will include:
    What is kratom?
    What is the chemical make-up?
    Kratom toxicity and side effects
    Testing for kratom
    Why testing is important?
    How to test for kratom
    What testing will tell you
    This episode features Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. 
    ----more----
    You may download a PDF version of this presentation here>>
    To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    21 min
  • Why and when to use oral fluid testing
    Today's podcast will cover why and when to use oral fluid testing. Some key topics shared will include:
    What is oral fluid testing?
    Comparison of oral fluid testing to other methods of testing
    The benefits of oral fluid testing?
    Some of the drugs oral fluid testing can identify?
    How are the drugs identified?
    How is the sample collected?
    Discussion on some of the key collection issues
    The episode features Les Edinboro, PhD, Quest Diagnostics executive science director, toxicology and drug monitoring, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. 
    ----more----
    You may download a PDF version of this presentation here >>Download the oral fluid specimen collection instructions PDF here >>Download the oral fluid testing brochure PDF here >>
    To listen to other podcasts in our series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.
    28 min
  • Dangerous drug combinations
    Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. Drs Gudin and Kain will be discussing “dangerous drug combinations.”
    20 min

About Topics in Drug Testing from Quest Diagnostics

From the publisher's feed

Tune in for expert insights on the latest in toxicology and drug testing.